Radiation Safety and Electrophysiologists: Radiation Protection Status - Go for Zero Fluoroscopy European Heart Rhythm Association Registry.


Journal

Cardiology
ISSN: 1421-9751
Titre abrégé: Cardiology
Pays: Switzerland
ID NLM: 1266406

Informations de publication

Date de publication:
Historique:
received: 15 05 2020
accepted: 03 05 2021
pubmed: 5 7 2021
medline: 22 12 2021
entrez: 4 7 2021
Statut: ppublish

Résumé

The purpose of this study was to analyze electrophysiologists' radiation-protective devices for occupational exposure across European countries. Data reported herein were gathered from the international, multicenter prospective Go for Zero Fluoroscopy registry performed in years 2018-2019. The registry encompassed 25 European electrophysiological centers from 14 countries and up to 5 operators from each center. The analysis included 95 operators (median age: 39 years, 85% of male, median training time: 5 years). The most frequently used X-ray protection tools (used by ≥80% of the group) were lead aprons, thyroid shields, screens below the table, glass in the laboratory, and least often (<7%) protective gloves and cabin. No statistically significant differences regarding the number of procedures performed monthly, electrophysiologists' experience and gender, and radiation exposure dose or radiation protection tools were observed, except lead thyroid shields and eyeglasses, which were more often used in case of fewer electrophysiological procedures performed (<20 procedures per month). Operators who were protected by >4 X-ray protection tools were exposed to lower radiation levels than those who were protected by ≤4 X-ray protection tools (median radiation exposure: 0.6 [0.2-1.1] vs. 0.2 [0.1-0.2] mSv per month, p < 0.0001; 1.1 [0.1-12.0] vs. 0.5 [0.1-1.1] mSv per year, p < 0.0001), respectively. Electrophysiologists' radiation-protective devices for occupational exposure are similar across European centers and in accordance with the applicable X-ray protection protocols, irrespective of the level of experience, number of monthly performed EP procedures, and gender.

Sections du résumé

BACKGROUND BACKGROUND
The purpose of this study was to analyze electrophysiologists' radiation-protective devices for occupational exposure across European countries.
METHODS METHODS
Data reported herein were gathered from the international, multicenter prospective Go for Zero Fluoroscopy registry performed in years 2018-2019. The registry encompassed 25 European electrophysiological centers from 14 countries and up to 5 operators from each center.
RESULTS RESULTS
The analysis included 95 operators (median age: 39 years, 85% of male, median training time: 5 years). The most frequently used X-ray protection tools (used by ≥80% of the group) were lead aprons, thyroid shields, screens below the table, glass in the laboratory, and least often (<7%) protective gloves and cabin. No statistically significant differences regarding the number of procedures performed monthly, electrophysiologists' experience and gender, and radiation exposure dose or radiation protection tools were observed, except lead thyroid shields and eyeglasses, which were more often used in case of fewer electrophysiological procedures performed (<20 procedures per month). Operators who were protected by >4 X-ray protection tools were exposed to lower radiation levels than those who were protected by ≤4 X-ray protection tools (median radiation exposure: 0.6 [0.2-1.1] vs. 0.2 [0.1-0.2] mSv per month, p < 0.0001; 1.1 [0.1-12.0] vs. 0.5 [0.1-1.1] mSv per year, p < 0.0001), respectively.
CONCLUSIONS CONCLUSIONS
Electrophysiologists' radiation-protective devices for occupational exposure are similar across European centers and in accordance with the applicable X-ray protection protocols, irrespective of the level of experience, number of monthly performed EP procedures, and gender.

Identifiants

pubmed: 34218228
pii: 000517000
doi: 10.1159/000517000
doi:

Types de publication

Journal Article Multicenter Study

Langues

eng

Sous-ensembles de citation

IM

Pagination

600-606

Informations de copyright

© 2021 S. Karger AG, Basel.

Auteurs

Bartosz Krzowski (B)

1st Department of Cardiology, Medical University of Warsaw, Warsaw, Poland.

Monika Gawałko (M)

1st Department of Cardiology, Medical University of Warsaw, Warsaw, Poland.
1 Department of Cardiology, Maastricht University Medical Centre and Cardiovascular Research Institute Maastricht, Maastricht, The Netherlands.
Institute of Pharmacology, West German Heart and Vascular Centre, University Duisburg-Essen, Essen, Germany.

Michał Peller (M)

1st Department of Cardiology, Medical University of Warsaw, Warsaw, Poland.

Piotr Lodziński (P)

1st Department of Cardiology, Medical University of Warsaw, Warsaw, Poland.

Marcin Grabowski (M)

1st Department of Cardiology, Medical University of Warsaw, Warsaw, Poland.

Tom De Potter (T)

Cardiovascular Center, OLV Hospital, Aalst, Belgium.

Lukas Fiedler (L)

Department of Internal Medicine II, General Hospital Wiener Neustadt, Wiener Neustadt, Austria.

Sabine Ernst (S)

Royal Brompton Hospital, London, United Kingdom.

David Duncker (D)

Department of Cardiology and Angiology, Rhythmology and Electrophysiology, Hannover Medical School, Hannover, Germany.

Michał Chudzik (M)

Department of Cardiology, Medical University of Lodz, Łódź, Poland.

Rodrigue Garcia (R)

Rhythmology Department, CHU de Poitiers, Poitiers, France.

Vincenzo Russo (V)

Department of Translational Medical Sciences, Chair of Cardiology, University of Campania "Luigi Vanvitelli" - Monaldi Hospital, Naples, Italy.

Andriy Yakushev (A)

Amosov National institute of cardiovascular surgery, Kyiv, Ukraine.

Jedrzej Kosiuk (J)

Rhythmology Department, Helios Clinic Koethen, Koethen, Germany.

Paweł Balsam (P)

1st Department of Cardiology, Medical University of Warsaw, Warsaw, Poland.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH